(PharmaNewsWire.Com, January 21, 2017 ) The report "Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), by Technology and by Product - Global Forecast to 2020", the Global Apheresis Market is Poised to Reach USD 2.5 Billion by 2020.
Browse 139 tables and 45 figures spread through 195 Pages and in-depth TOC on "Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), by Technology and by Product - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
Currently, apheresis procedures are mostly preferred over the existing whole blood collection and therapeutic methods. The increasing awareness about apheresis blood collection, rapid growth in aging population, and increasing number of surgical procedures and emergency treatment cases in hospitals, worldwide, are some of the key factors that are contributing to the growth of the apheresis market. However, factors such as high cost of apheresis procedures, lack of awareness regarding the apheresis process in emerging and developing markets, and challenges in donor recruitment are restraining the growth of the market.
In this report, the apheresis market is segmented on the basis of product, procedure, technology, application, and region. On the basis of product, the market is segmented into devices and disposables. In 2014, the disposables segment accounted for the largest share 85.1% of the global apheresis market, and is poised to grow at a CAGR of 11.6% during the forecast period. The large share of this segment is mainly attributed to the increasing demand for disposables with the increasing number of therapeutic apheresis procedures, and increasing trend towards apheresis blood collection.
On the basis of technology, the apheresis market is divided into centrifugation and membrane separation. The centrifugation segment accounted for the largest share 75.3% of the global apheresis market in 2014, owing to the advantages offered by centrifugation technology over membrane separation.
On the basis of application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share 46.5% of the global apheresis market in 2014. The high share of this segment is attributed to the increasing demand for source plasma from biopharmaceutical companies, increasing source plasma collections across the globe, and increasing application areas of plasma fractionation products.
Geographically, North America accounted for the largest share of ~47.8% of the apheresis market in 2014, followed by Europe, Asia-Pacific, and the RoW. The large share of North America in the global apheresis market is mainly attributed to greater accessibility to advanced technologies, increasing opportunities for apheresis products in the plasma collection and fractionation markets, and established distribution channels in this region as compared to Europe and APAC. However, the Asia-Pacific region is expected to be the fastest-growing apheresis market during the forecast period. Increasing demand for blood components for the treatment of the large patient population, rapid development in the healthcare infrastructure, and growing per capita healthcare expenditure in these countries are contributing to the growth of the apheresis market in the APAC region during the forecast period.
The global apheresis market is consolidated in nature, with top five companies accounting for a market share of nearly 80%–85% in 2014. Some of the key players in this market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan) and Therakos, Inc. (U.S.). The leading players in this market have built a strong market position over the years by focusing on agreements, collaborations, and partnerships, and expanding their geographic presence in emerging markets in order to widen their revenue streams. These still remain the actively adopted strategies by leading players in this market, in order to achieve sustainable revenue growth in the competitive apheresis market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
